Coegin Pharma AB reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was SEK 0.227 million compared to SEK 1.7 million a year ago. Net loss was SEK 6.52 million compared to SEK 12.8 million a year ago. Basic loss per share from continuing operations was SEK 0.7 compared to SEK 1.84 a year ago. Diluted loss per share from continuing operations was SEK 0.7 compared to SEK 1.84 a year ago.
For the six months, revenue was SEK 0.302 million compared to SEK 2.82 million a year ago. Net loss was SEK 13 million compared to SEK 19.29 million a year ago. Basic loss per share from continuing operations was SEK 1.44 compared to SEK 2.85 a year ago. Diluted loss per share from continuing operations was SEK 1.44 compared to SEK 2.85 a year ago.